Point72 Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $262K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $4.54M | Sell |
|
|||||
|
2023
Q2 | $18M | Buy |
|
|||||
|
2023
Q1 | $10.9M | Sell |
|
|||||
|
2022
Q4 | $28.1M | Sell |
|
|||||
|
2022
Q3 | $29.2M | Buy |
|
|||||
|
2022
Q2 | $24.2M | Sell |
|
|||||
|
2022
Q1 | $39.3M | Buy |
|
|||||
|
2021
Q4 | $9.35M | Buy |
|
|||||
|
2021
Q3 | $7.04M | Sell |
|
|||||
|
2021
Q2 | $8.4M | Buy |
|
|||||
|
2021
Q1 | $8.26M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $5.39M | Sell |
|
|||||
|
2018
Q1 | $12.8M | Sell |
|
|||||
|
2017
Q4 | $19.5M | Sell |
|
|||||
|
2017
Q3 | $23M | Buy |
|
|||||
|
2017
Q2 | $23.4M | Buy |
|
|||||
|
2017
Q1 | $13.7M | Buy |
|